CYP3A4 and epilepsy: Follow- up studies can determine whether the metabolism of antiepileptic drugs is related to the expression of CYP3A1 and P-gp in the intestinal tract and whether changes in the intestinal flora of patients with epilepsy have an impact on the expression of CYP3A and P-gp in the intestinal wall and in an epilepsy model.